Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Amarin Corporation plc (ADR) (AMRN), Ariad Pharmaceuticals, Inc. (ARIA): 5 Stocks That Fell Every Day Last Week

Page 1 of 2

Amarin Corporation plc (ADR) (NASDAQ:AMRN)

Some stocks take a pounding, but there’s usually what they call a dead-cat bounce. Even if a stock’s inevitable path is to head lower, there’s usually a respite in the downticks.

It doesn’t always pan out that way.

Last week was rather uneventful for the market. The Dow 30, Nasdaq, and S&P 500 all closed lower, but none of the market gauges shed more than 0.2% of their value.

Some stocks weren’t that lucky. More than a few actively traded companies fell every single trading day last week, and more often than not it happened without any material news. Investors just decided to move on, and the small daily downticks added up to double-digit percentage share-price declines.

Let’s take a closer look at five of the companies that saw their share prices drop in each of this past week’s five trading days.

Company Mar. 22 Weekly Loss
JDS Uniphase Corp (NASDAQ:JDSU) $13.47 (12%)
Nabors Industries Ltd. (NYSE:NBR) $15.41 (11%)
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) $19.38 (11%)
Dendreon Corporation (NASDAQ:DNDN) $4.89 (10%)
Amarin Corporation plc (ADR) (NASDAQ:AMRN) $7.63 (10%)

Source: Barron’s.

JDS Uniphase offered product updates during the Optical Fiber Communication Conference/National Fiber Optic Engineers Conference during the week. The optical networking specialist announced the availability of several new items. It wasn’t enough. Even though JDS Uniphase is still growing — analysts see marginal upticks in revenue and profitability for the fiscal year ending in June — investors were still set on rotating out of a company that had hit a fresh 52-week high last month.

Nabors Industries slipped despite an analyst upgrade. Zacks Equity Research is boosting its rating on Nabors from underperform to neutral, encouraged in part by the onshore contractor’s recent decision to start paying quarterly dividends. Then again, it’s not as if a hold rating is something to scrapbook.

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) had good news on Friday, as the European equivalent of the FDA approved the company’s chronic myeloid leukemia (CML) drug Iclusig. One can argue that the market was already banking on approval, but is that any excuse for Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) to close lower every single day last week?

Page 1 of 2

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!